IGF2BP1 and cancer: As amplification and elevated mRNA levels accounted for most of the genetic alterations of prognostic IGF2BP1, we consequently analyzed mRNA levels in a large patient cohort of 15,776 samples with 33 types of human cancer and 31 types of adjacent normal tissues in TCGA datasets and GTEx samples accessible through UCSC Xena.